Riley Griffiths North America diagnostic specialty antibodies market is expected to grow by 4.2% annually in the forecast period and reach $10.86 billion by 2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase … Read more
Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such … Read more
Asia Pacific biosurgery market will grow by 8.9% annually with a total addressable market cap of $33.2 billion over 2021-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.Highlighted with 31 tables … Read more
Europe biosurgery market accounted for $3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.Highlighted with 34 tables and 50 figures, … Read more
North America biosurgery market is expected to grow by 5.9% annually in the forecast period and reach $8,079.9 million by 2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.Highlighted with 24 … Read more
Global biosurgery market will reach $21.55 billion by 2027, growing by 6.6% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.Highlighted with 83 tables and 82 figures, this 155-page … Read more
Asia Pacific amyotrophic lateral sclerosis treatment market will grow by 8.0% annually with a total addressable market cap of $1,244.1 million over 2021-2027 owing to the rising geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies.Highlighted with 28 tables and 34 figures, this … Read more
Europe amyotrophic lateral sclerosis treatment market accounted for $129.5 million in 2020 and will grow by 5.4% annually over 2020-2027 owing to the rising geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies.Highlighted with 31 tables and 35 figures, this 86-page report “Europe … Read more
North America amyotrophic lateral sclerosis treatment market is expected to grow by 5.0% annually in the forecast period and reach $270.6 million by 2027 owing to the increasing geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies.Highlighted with 21 tables and 31 figures, … Read more
Global amyotrophic lateral sclerosis treatment market will reach $762.3 million by 2027, growing by 5.8% annually over 2020-2027 owing to the increasing geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies.Highlighted with 80 tables and 67 figures, this 139-page report “Global Amyotrophic Lateral … Read more